STAT+: Pharmalittle: FDA decision on Novavax Covid shot could be delayed; new drug prices rose 20% annually in recent years
The FDA needs to review changes to the manufacturing process used by Novavax before it can authorize the company’s Covid-19 vaccine.
Good morning, everyone, and how are you today? We are doing just fine, thank you, as we wind up a quick sojourn
